Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04319848
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:19.116919+00:00
Published At
2025-09-12T00:00:00+00:00
Record Updated At
2025-09-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mild to Moderate Corneal Endothelial Decompensation", "Bullous Keratopathy", "Fuchs\u0027 Endothelial Dystrophy", "Post-surgical Corneal Decompensation (Irreversible)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-12"
protocolSection.identificationModule.nctId
"NCT04319848"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mild to Moderate Corneal Endothelial Decompensation (protocolSection.conditionsModule.conditions)
  • Bullous Keratopathy (protocolSection.conditionsModule.conditions)
  • Fuchs' Endothelial Dystrophy (protocolSection.conditionsModule.conditions)
  • Post-surgical Corneal Decompensation (Irreversible) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.